Advances in mRNA Therapy for Cancer Treatment

Researchers have made significant progress in developing mRNA therapy as a promising approach in oncology, offering innovative applications such as tumor vaccines, protein replacement therapy, cell therapy, and gene therapy. However, challenges such as mRNA stability and delivery efficiency must be addressed for effective treatment. A recent review outlined the applications of mRNA therapy in oncology, as well as the utilization of nonviral vectors, encompassing organic, inorganic, and biomimetic systems.

Key Takeaways:

• mRNA therapy shows promise in oncology with innovative applications such as tumor vaccines, protein replacement therapy, cell therapy, and gene therapy.
• Challenges in mRNA stability and delivery efficiency must be addressed for effective treatment, including accurate organ or cell targeting, intelligent release mechanisms, and optimized administration routes.
• Recent advances in delivery system technologies, such as nonviral vectors and stimuli-responsive delivery systems, are crucial for precise mRNA delivery and enhancing treatment safety and efficacy.
• The development of noninvasive mRNA delivery systems designed for oral and pulmonary administration is a key area of research.
• The South China University of Technology is at the forefront of research in mRNA therapy, with a focus on delivery system technologies and the development of noninvasive delivery systems.
• Funders for this research include the National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, and National Natural Science Foundation of China.

Statistics:

• The review outlined by the South China University of Technology examined recent advances in mRNA delivery systems, including nonviral vectors and stimuli-responsive delivery systems.
• The review also discussed strategies for passive and active vector targeting, as well as the development of noninvasive mRNA delivery systems designed for oral and pulmonary administration.
• The research was funded by the National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, and National Natural Science Foundation of China.

Sources:

• Song Shen, et al., "Recent Advances in mRNA Delivery Systems for Cancer Therapy," Advanced Science, 2025.
• South China University of Technology, Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, People's Republic of China.
• National Key Research and Development Program of China.
• Basic and Applied Basic Research Foundation of Guangdong Province.
• National Natural Science Foundation of China.